Mino/iRFP cells are derived from the human mantle cell lymphoma (MCL) Mino cell line by stably integration of a constitutive miRFP670 stably expression construct. Mino cell line is a valuable model to study mantle cell lymphoma cancer biology and to test new drugs and therapeutic approaches for treating mantle cell lymphoma. Mino/iRFP cells stably express miRFP670, can be used for in vitro assays and in vivo imaging.